These findings might link liver dysfunction observed in obese patients to their low IGF-1 levels; furthermore, it has been shown that adiponectin is negatively correlated to hepatic insulin resistance and hepatic fat content [57]. The gene discussed is ADIPOQ; the disease is Insulin resistance.